2005N-0354 Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
FDA Comment Number : EC377
Submitter : Ms. sallee slagle Date & Time: 12/12/2005 02:12:41
Organization : Ms. sallee slagle
Category : Individual Consumer
Issue Areas/Comments
Dear FDA,
I am glad to hear that you are conducting a hearing on the advertising of psychiatric drugs. I truly believe their ads are very misleading and give false information.
The false info includes stating that psychiatric drugs handle a "chemical imbalance of the brain" or similarly, "correct neurotransmitter levels", etc. Psychiatrists don't know what a proper chemical imblance so therefore cannot say what is an improper balance, especially when there is no scientific test to prove such a diagnosis of a brain's chemical balance..

It is also misleading in their portrayal that psychiatric drugs are safe and effective.
These drugs have many severe effects and side effects so are not safe. The FDA approves these psychiatric drugs although they barely beat out the placebo and often lose out to using excercise in helping depression.
It's time you, the FDA, stop allowing these falcies. It is not denying the freedom of speech to advertise just we need honesty in advertising especially in the health and fitness field.
Please let me know by return email that you understand my comments.
Sallee Slagle
Nahant, MA